EP3419593
ENASIDENIB FOR USE IN THE TREATMENT OF RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
2.12.2016EP published:
23.3.2022EP application number:
16816810.2
EPO information:
European Patent Register
Max expiry date:
1.12.2036
Title in English:
ENASIDENIB FOR USE IN THE TREATMENT OF RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIALanguage of the patent:
English
Timeline
Today
2.12.2016EP application
23.3.2022EP Publication
Owner
Name:
Celgene CorporationAddress:
86 Morris Avenue, Summit, NJ 07901, US
Name:
Les Laboratoires ServierAddress:
50 rue Carnot, 92284 Suresnes Cedex, FR
Inventor
Name:
AMATANGELO, MichaelAddress:
Madison, NJ 07940, US
Name:
HU, XiaolanAddress:
Skillman, NJ 08558, US
Name:
THAKURTA, AnjanAddress:
Basking Ridge, NJ 07920, US
Name:
CHOE, Sung EunAddress:
Lexington, MA 02421, US
Name:
WU, BinAddress:
Belmont, MA 02478, US
Priority
Number:
201662300673 PDate:
26.2.2016Country:
US
Classification
Categories:
A61K 31/365, A61K 31/404, A61K 31/437, A61K 31/44, A61K 31/444, A61K 31/4709, A61K 31/496, A61K 31/497, A61K 31/5025, A61K 31/53, A61K 31/5377, A61K 31/551, A61K 31/553, A61K 45/06, A61K 9/00, A61P 35/00, A61P 35/02, C07D 251/52, C07D 401/14, C07D 403/14